Edition:
United Kingdom

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

18.85USD
16 Aug 2018
Change (% chg)

$0.36 (+1.95%)
Prev Close
$18.49
Open
$18.53
Day's High
$18.90
Day's Low
$18.19
Volume
145,121
Avg. Vol
299,303
52-wk High
$22.28
52-wk Low
$11.12

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.50 December 17 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.57 1.57 1.57 1.57

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 8 0.03 0.25 0.00 0.00
Quarter Ending Dec-18 8 0.97 5.00 0.00 3.45
Year Ending Dec-18 8 1.59 8.00 0.00 2.74
Year Ending Dec-19 7 3.41 11.00 0.00 4.62
Earnings (per share)
Quarter Ending Sep-18 8 -0.50 -0.40 -0.61 -0.38
Quarter Ending Dec-18 8 -0.50 -0.41 -0.62 -0.27
Year Ending Dec-18 8 -2.06 -1.83 -2.44 -1.87
Year Ending Dec-19 8 -2.10 -1.66 -2.78 -1.89

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 6.47 2.87 3.59 55.57
Quarter Ending Mar-18 0.03 0.00 0.03 100.00
Quarter Ending Dec-17 0.02 0.00 0.02 100.00
Quarter Ending Sep-17 0.19 0.00 0.19 100.00
Quarter Ending Jun-17 0.02 0.00 0.02 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.03 0.04 0.04 0.04 0.00
Quarter Ending Dec-18 0.97 0.97 0.97 0.97 3.45
Year Ending Dec-18 1.59 7.47 7.47 7.47 2.74
Year Ending Dec-19 3.41 3.42 3.42 3.42 4.62

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 1 0 1
Year Ending Dec-19 0 1 0 1
Earnings